BioCentury
ARTICLE | Clinical News

FluLaval regulatory update

October 9, 2006 7:00 AM UTC

FDA approved a BLA for FluLaval influenza vaccine to immunize adults 18 years and older against influenza virus types A and B. GSK gained the vaccine, which is marketed in Canada as Fluviral, through...